CME Group (NASDAQ:CME) Stock Price Expected to Rise, TD Cowen Analyst Says

CME Group (NASDAQ:CME) had its price objective boosted by equities researchers at TD Cowen from $328.00 to $340.00 in a research note issued to investors on Thursday,MarketScreener reports. The firm currently has a “buy” rating on the financial services provider’s stock. TD Cowen’s target price would suggest a potential upside of 12.49% from the stock’s previous close.

A number of other equities analysts also recently weighed in on CME. Argus reaffirmed a “hold” rating on shares of CME Group in a research note on Wednesday, March 4th. JPMorgan Chase & Co. lifted their price target on shares of CME Group from $262.00 to $266.00 and gave the company an “underweight” rating in a report on Thursday, February 5th. Keefe, Bruyette & Woods initiated coverage on shares of CME Group in a report on Wednesday. They issued a “market perform” rating and a $305.00 price target for the company. Raymond James Financial lifted their price target on shares of CME Group from $310.00 to $320.00 and gave the company an “outperform” rating in a report on Monday. Finally, Bank of America lifted their price target on shares of CME Group from $201.00 to $209.00 in a report on Wednesday, December 10th. Two investment analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, CME Group has an average rating of “Moderate Buy” and a consensus price target of $307.88.

CME Group Price Performance

Shares of CME opened at $302.26 on Thursday. CME Group has a fifty-two week low of $251.90 and a fifty-two week high of $329.16. The company has a market capitalization of $108.40 billion, a price-to-earnings ratio of 27.07, a price-to-earnings-growth ratio of 3.25 and a beta of 0.26. The firm has a 50-day simple moving average of $306.06 and a 200-day simple moving average of $284.06. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.03 and a current ratio of 1.03.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share for the quarter, topping the consensus estimate of $2.75 by $0.02. CME Group had a net margin of 62.45% and a return on equity of 14.65%. The business had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the prior year, the firm earned $2.52 earnings per share. The business’s quarterly revenue was up 8.1% compared to the same quarter last year. On average, equities research analysts anticipate that CME Group will post 10.49 earnings per share for the current year.

Insider Activity

In other CME Group news, General Counsel Jonathan L. Marcus sold 3,291 shares of the business’s stock in a transaction dated Tuesday, March 17th. The shares were sold at an average price of $333.37, for a total transaction of $1,097,120.67. Following the sale, the general counsel directly owned 7,192 shares in the company, valued at approximately $2,397,597.04. The trade was a 31.39% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Martin J. Gepsman sold 300 shares of the business’s stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $305.90, for a total transaction of $91,770.00. Following the sale, the director owned 24,999 shares in the company, valued at $7,647,194.10. This trade represents a 1.19% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 8,539 shares of company stock valued at $2,713,821. 0.30% of the stock is owned by company insiders.

Institutional Trading of CME Group

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. West Family Investments Inc. raised its stake in CME Group by 1.2% during the 3rd quarter. West Family Investments Inc. now owns 3,062 shares of the financial services provider’s stock valued at $827,000 after purchasing an additional 37 shares during the last quarter. Asset Dedication LLC lifted its position in CME Group by 64.9% during the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 37 shares during the period. Northwestern Mutual Investment Management Company LLC increased its stake in CME Group by 0.3% in the fourth quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock valued at $3,147,000 after purchasing an additional 37 shares in the last quarter. Rehmann Capital Advisory Group raised its holdings in CME Group by 4.3% in the third quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock worth $243,000 after purchasing an additional 37 shares during the period. Finally, Atlatl Advisers LLC raised its holdings in CME Group by 1.8% in the third quarter. Atlatl Advisers LLC now owns 2,126 shares of the financial services provider’s stock worth $574,000 after purchasing an additional 38 shares during the period. 87.75% of the stock is currently owned by institutional investors.

Key Headlines Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Record Q1 volumes — CME reported international average daily volume (ADV) hit a record 11.4M contracts in Q1, up ~30% YoY, with all major product suites posting quarterly international ADV records; stronger ADV typically boosts transaction revenue and supports earnings durability. CME Group International ADV Reaches Record 11.4M Contracts in Q1 2026
• Positive Sentiment: Crypto product expansion — CME is adding Avalanche (AVAX) and Sui (SUI) futures (micro and standard sizes) with a planned May 4 rollout, and is advancing a broader 24/7 crypto offering; these moves expand addressable market and could lift future trading volumes and fees. CME Group to Launch Avalanche and Sui Futures
• Positive Sentiment: Analyst optimism — several broker notes surfaced: an average “Moderate Buy” consensus and a Raymond James note saying the stock is likely to rise, reflecting analyst confidence in CME’s revenue trends and product-led growth. CME Given Average Recommendation of Moderate Buy
• Positive Sentiment: Barclays raised its price target to $344 (from $312) — a material lift to modeled upside even as the firm kept an equal-weight rating, signaling higher long-term valuation assumptions. Barclays Adjusts Price Target on CME Group to $344
• Neutral Sentiment: New coverage and modest PTs — Keefe, Bruyette & Woods started coverage with a “market perform” and $305 target, a cautious near-term view that may limit upside from some investors. Keefe Bruyette & Woods Starts Coverage
• Neutral Sentiment: Macro/market flow context — CME’s market data is being widely cited (e.g., Fed-cut odds), and large block trades in oil and other futures routed through venues CME operates have driven episodic volatility and volume; this boosts ADV but can also cause short-term price swings in the stock. Markets Shift Toward Potential Fed Rate Cut; CME Data Cited
• Neutral Sentiment: Third‑party SPAC crypto financing references CME rates — an Evernorth SEC filing ties XRP pricing/valuation mechanics to CME CF rates, highlighting CME’s role in broader crypto market structure but with indirect and uncertain revenue implication. Evernorth Amended SEC Filing Deepens XRP Role
• Negative Sentiment: Regulatory/approval risk for crypto products — the AVAX and SUI futures launches are pending regulatory approval; any delays or restrictions could push out expected revenue gains and keep investor caution elevated. CME Group Launch Avalanche and Sui Futures

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.